Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)

NCT03154827 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Due to lack of enrollment

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: BL-8040
DRUG: Atezolizumab

Sponsor

BioLineRx, Ltd.

Collaborators

[object Object]